Skip to main content
Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
11.11
+0.31 (2.87%)
Jan 30, 2025, 4:00 PM EST - Market closed

Emergent BioSolutions Revenue

Emergent BioSolutions had revenue of $293.80M in the quarter ending September 30, 2024, with 8.61% growth. This brings the company's revenue in the last twelve months to $1.13B, up 2.05% year-over-year. In the year 2023, Emergent BioSolutions had annual revenue of $1.05B, down -6.10%.

Revenue (ttm)
$1.13B
Revenue Growth
+2.05%
P/S Ratio
0.50
Revenue / Employee
$703,438
Employees
1,600
Market Cap
601.99M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.05B-68.20M-6.10%
Dec 31, 20221.12B-656.10M-36.99%
Dec 31, 20211.77B196.30M12.45%
Dec 31, 20201.58B471.30M42.61%
Dec 31, 20191.11B323.60M41.36%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.95B
Revenue Rankings

EBS News

More News